Multiple signaling pathways contribute to venetoclax resistance in CLL, notably the PI3K/AKT/mTOR and NF-κB pathways, each with distinct roles in promoting cell survival and proliferation. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.